Logo image of CFX.DE

CAPITAL ONE FINANCIAL CORP (CFX.DE) Stock Fundamental Analysis

FRA:CFX - Deutsche Boerse Ag - US14040H1059 - Common Stock - Currency: EUR

170  0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CFX. CFX was compared to 9 industry peers in the Consumer Finance industry. CFX scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CFX has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year CFX was profitable.
CFX had a positive operating cash flow in the past year.
CFX had positive earnings in each of the past 5 years.
In the past 5 years CFX always reported a positive cash flow from operatings.
CFX.DE Yearly Net Income VS EBIT VS OCF VS FCFCFX.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

1.2 Ratios

Looking at the Return On Assets, with a value of 0.93%, CFX is doing worse than 62.50% of the companies in the same industry.
With a Return On Equity value of 7.19%, CFX perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
ROA 0.93%
ROE 7.19%
ROIC N/A
ROA(3y)1.14%
ROA(5y)1.35%
ROE(3y)9.53%
ROE(5y)10.43%
ROIC(3y)N/A
ROIC(5y)N/A
CFX.DE Yearly ROA, ROE, ROICCFX.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With a decent Profit Margin value of 11.51%, CFX is doing good in the industry, outperforming 75.00% of the companies in the same industry.
CFX's Profit Margin has declined in the last couple of years.
The Operating Margin and Gross Margin are not available for CFX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 11.51%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-33.88%
PM growth 5Y-8.95%
GM growth 3YN/A
GM growth 5YN/A
CFX.DE Yearly Profit, Operating, Gross MarginsCFX.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

4

2. Health

2.1 Basic Checks

CFX does not have a ROIC to compare to the WACC, probably because it is not profitable.
CFX has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CFX has been reduced compared to 5 years ago.
The debt/assets ratio for CFX has been reduced compared to a year ago.
CFX.DE Yearly Shares OutstandingCFX.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
CFX.DE Yearly Total Debt VS Total AssetsCFX.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100B 200B 300B 400B

2.2 Solvency

The Debt to FCF ratio of CFX is 2.26, which is a good value as it means it would take CFX, 2.26 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.26, CFX belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
CFX has a Debt/Equity ratio of 0.66. This is a neutral value indicating CFX is somewhat dependend on debt financing.
CFX has a Debt to Equity ratio of 0.66. This is amongst the best in the industry. CFX outperforms 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 2.26
Altman-Z N/A
ROIC/WACCN/A
WACC13.12%
CFX.DE Yearly LT Debt VS Equity VS FCFCFX.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
CFX.DE Yearly Current Assets VS Current LiabilitesCFX.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 10.28% over the past year.
CFX shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 4.14% yearly.
CFX shows a small growth in Revenue. In the last year, the Revenue has grown by 6.50%.
Measured over the past years, CFX shows a small growth in Revenue. The Revenue has been growing by 6.47% on average per year.
EPS 1Y (TTM)10.28%
EPS 3Y-19.6%
EPS 5Y4.14%
EPS Q2Q%26.48%
Revenue 1Y (TTM)6.5%
Revenue growth 3Y8.72%
Revenue growth 5Y6.47%
Sales Q2Q%6.36%

3.2 Future

Based on estimates for the next years, CFX will show a small growth in Earnings Per Share. The EPS will grow by 4.97% on average per year.
Based on estimates for the next years, CFX will show a small growth in Revenue. The Revenue will grow by 4.60% on average per year.
EPS Next Y13.87%
EPS Next 2Y15.37%
EPS Next 3Y15.53%
EPS Next 5Y4.97%
Revenue Next Year5.63%
Revenue Next 2Y5.61%
Revenue Next 3Y5.49%
Revenue Next 5Y4.6%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CFX.DE Yearly Revenue VS EstimatesCFX.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20B 40B 60B
CFX.DE Yearly EPS VS EstimatesCFX.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15 20 25

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 13.12, the valuation of CFX can be described as correct.
Compared to the rest of the industry, the Price/Earnings ratio of CFX indicates a rather cheap valuation: CFX is cheaper than 87.50% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.52, CFX is valued rather cheaply.
CFX is valuated reasonably with a Price/Forward Earnings ratio of 10.46.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CFX indicates a somewhat cheap valuation: CFX is cheaper than 62.50% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.25, CFX is valued rather cheaply.
Industry RankSector Rank
PE 13.12
Fwd PE 10.46
CFX.DE Price Earnings VS Forward Price EarningsCFX.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, CFX is valued a bit cheaper than 75.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.72
EV/EBITDA N/A
CFX.DE Per share dataCFX.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CFX's earnings are expected to grow with 15.53% in the coming years.
PEG (NY)0.95
PEG (5Y)3.17
EPS Next 2Y15.37%
EPS Next 3Y15.53%

4

5. Dividend

5.1 Amount

CFX has a Yearly Dividend Yield of 1.25%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.22, CFX pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.38, CFX's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.25%

5.2 History

On average, the dividend of CFX grows each year by 6.36%, which is quite nice.
Dividend Growth(5Y)6.36%
Div Incr Years0
Div Non Decr Years3
CFX.DE Yearly Dividends per shareCFX.DE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

25.36% of the earnings are spent on dividend by CFX. This is a low number and sustainable payout ratio.
The dividend of CFX is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP25.36%
EPS Next 2Y15.37%
EPS Next 3Y15.53%
CFX.DE Yearly Income VS Free CF VS DividendCFX.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B
CFX.DE Dividend Payout.CFX.DE Dividend Payout, showing the Payout Ratio.CFX.DE Dividend Payout.PayoutRetained Earnings

CAPITAL ONE FINANCIAL CORP

FRA:CFX (6/5/2025, 7:00:00 PM)

170

0 (0%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryConsumer Finance
Earnings (Last)04-22 2025-04-22/amc
Earnings (Next)07-21 2025-07-21/amc
Inst Owners93.42%
Inst Owner ChangeN/A
Ins Owners1.15%
Ins Owner ChangeN/A
Market Cap108.82B
Analysts80.77
Price Target195.04 (14.73%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.25%
Yearly Dividend2.67
Dividend Growth(5Y)6.36%
DP25.36%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.7%
Min EPS beat(2)8.56%
Max EPS beat(2)8.83%
EPS beat(4)3
Avg EPS beat(4)7.65%
Min EPS beat(4)-5.56%
Max EPS beat(4)18.76%
EPS beat(8)5
Avg EPS beat(8)6.79%
EPS beat(12)5
Avg EPS beat(12)-2.97%
EPS beat(16)9
Avg EPS beat(16)3.44%
Revenue beat(2)0
Avg Revenue beat(2)-1.34%
Min Revenue beat(2)-1.47%
Max Revenue beat(2)-1.2%
Revenue beat(4)1
Avg Revenue beat(4)-0.95%
Min Revenue beat(4)-1.66%
Max Revenue beat(4)0.54%
Revenue beat(8)2
Avg Revenue beat(8)-0.75%
Revenue beat(12)3
Avg Revenue beat(12)-0.83%
Revenue beat(16)7
Avg Revenue beat(16)-0.05%
PT rev (1m)3.29%
PT rev (3m)-5.9%
EPS NQ rev (1m)-66.36%
EPS NQ rev (3m)-67.25%
EPS NY rev (1m)0.35%
EPS NY rev (3m)-0.36%
Revenue NQ rev (1m)24.15%
Revenue NQ rev (3m)23.47%
Revenue NY rev (1m)0.41%
Revenue NY rev (3m)0.34%
Valuation
Industry RankSector Rank
PE 13.12
Fwd PE 10.46
P/S 3.13
P/FCF 6.72
P/OCF 6.27
P/B 1.96
P/tB 2.59
EV/EBITDA N/A
EPS(TTM)12.96
EY7.62%
EPS(NY)16.25
Fwd EY9.56%
FCF(TTM)25.31
FCFY14.89%
OCF(TTM)27.1
OCFY15.94%
SpS54.31
BVpS86.9
TBVpS65.54
PEG (NY)0.95
PEG (5Y)3.17
Profitability
Industry RankSector Rank
ROA 0.93%
ROE 7.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 11.51%
GM N/A
FCFM 46.62%
ROA(3y)1.14%
ROA(5y)1.35%
ROE(3y)9.53%
ROE(5y)10.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-33.88%
PM growth 5Y-8.95%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 2.26
Debt/EBITDA N/A
Cap/Depr 40.24%
Cap/Sales 3.29%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 405.06%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score7
WACC13.12%
ROIC/WACCN/A
Cap/Depr(3y)32.03%
Cap/Depr(5y)27.28%
Cap/Sales(3y)2.81%
Cap/Sales(5y)2.64%
Profit Quality(3y)330.76%
Profit Quality(5y)352.51%
High Growth Momentum
Growth
EPS 1Y (TTM)10.28%
EPS 3Y-19.6%
EPS 5Y4.14%
EPS Q2Q%26.48%
EPS Next Y13.87%
EPS Next 2Y15.37%
EPS Next 3Y15.53%
EPS Next 5Y4.97%
Revenue 1Y (TTM)6.5%
Revenue growth 3Y8.72%
Revenue growth 5Y6.47%
Sales Q2Q%6.36%
Revenue Next Year5.63%
Revenue Next 2Y5.61%
Revenue Next 3Y5.49%
Revenue Next 5Y4.6%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y16.12%
FCF growth 3Y13.45%
FCF growth 5Y1.48%
OCF growth 1Y17.39%
OCF growth 3Y13.84%
OCF growth 5Y1.76%